William Plovanic
Stock Analyst at Canaccord Genuity
(3.25)
# 816
Out of 4,825 analysts
129
Total ratings
39.66%
Success rate
2.81%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Technologies | Maintains: Buy | $152 → $139 | $131.16 | +5.98% | 10 | May 2, 2025 | |
| DXCM DexCom | Maintains: Buy | $103 → $106 | $81.62 | +29.87% | 6 | May 2, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $58 → $59 | $21.45 | +175.06% | 4 | May 1, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $71 → $75 | $75.53 | -0.70% | 26 | Apr 25, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $23 → $18 | $7.95 | +126.42% | 8 | Apr 8, 2025 | |
| TLSI TriSalus Life Sciences | Maintains: Buy | $11 | $5.05 | +117.82% | 4 | Mar 28, 2025 | |
| ATRC AtriCure | Maintains: Buy | $66 → $52 | $30.02 | +73.22% | 11 | Mar 28, 2025 | |
| TMDX TransMedics Group | Maintains: Buy | $104 | $89.98 | +15.58% | 5 | Mar 11, 2025 | |
| STIM Neuronetics | Maintains: Buy | $5 → $8 | $4.59 | +74.29% | 3 | Mar 5, 2025 | |
| CBLL CeriBell | Maintains: Buy | $33 | $16.31 | +102.39% | 4 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $101 | $71.90 | +40.48% | 3 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $269 → $304 | $257.00 | +18.29% | 3 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $101 | $104.93 | -3.75% | 9 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $7.31 | +105.20% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $12 | $9.29 | +29.17% | 5 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $120 → $115 | $102.05 | +12.69% | 2 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $296.47 | -4.21% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $11.94 | +109.38% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $3.77 | +218.73% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $95.75 | -26.89% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $19.07 | +151.70% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $4.40 | +400.00% | 3 | Jul 25, 2023 |
iRhythm Technologies
May 2, 2025
Maintains: Buy
Price Target: $152 → $139
Current: $131.16
Upside: +5.98%
DexCom
May 2, 2025
Maintains: Buy
Price Target: $103 → $106
Current: $81.62
Upside: +29.87%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $58 → $59
Current: $21.45
Upside: +175.06%
Edwards Lifesciences
Apr 25, 2025
Maintains: Hold
Price Target: $71 → $75
Current: $75.53
Upside: -0.70%
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $7.95
Upside: +126.42%
TriSalus Life Sciences
Mar 28, 2025
Maintains: Buy
Price Target: $11
Current: $5.05
Upside: +117.82%
AtriCure
Mar 28, 2025
Maintains: Buy
Price Target: $66 → $52
Current: $30.02
Upside: +73.22%
TransMedics Group
Mar 11, 2025
Maintains: Buy
Price Target: $104
Current: $89.98
Upside: +15.58%
Neuronetics
Mar 5, 2025
Maintains: Buy
Price Target: $5 → $8
Current: $4.59
Upside: +74.29%
CeriBell
Feb 26, 2025
Maintains: Buy
Price Target: $33
Current: $16.31
Upside: +102.39%
Jan 10, 2025
Maintains: Buy
Price Target: $92 → $101
Current: $71.90
Upside: +40.48%
Dec 9, 2024
Maintains: Buy
Price Target: $269 → $304
Current: $257.00
Upside: +18.29%
Dec 9, 2024
Maintains: Buy
Price Target: $98 → $101
Current: $104.93
Upside: -3.75%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $7.31
Upside: +105.20%
Oct 4, 2024
Maintains: Buy
Price Target: $13 → $12
Current: $9.29
Upside: +29.17%
Sep 10, 2024
Maintains: Hold
Price Target: $120 → $115
Current: $102.05
Upside: +12.69%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $296.47
Upside: -4.21%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $11.94
Upside: +109.38%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $3.77
Upside: +218.73%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $95.75
Upside: -26.89%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $19.07
Upside: +151.70%
Jul 25, 2023
Maintains: Buy
Price Target: $21 → $22
Current: $4.40
Upside: +400.00%